I started my career as an adult cardiologist, but I found that I enjoyed working with children and their families more. As executive co-director of the Heart Institute at Cincinnati Children’s, I work with my colleagues to establish a world-leading multidisciplinary team that provides the highest level of clinical care for children and adults with congenital heart disease.
As a general cardiologist and chief of Pediatric Cardiology, I treat children with heart disease. I have more than 30 years of experience with some of the best programs in the world. My philosophy of care is to provide unremitting attention to detail, with the goal of improving care. I’ve written more than 300 peer-reviewed publications, more than 30 book chapters, and co-edited seven textbooks. I currently hold over 15 U.S. and international patents.
In my research, my colleagues and I are studying ways to protect the heart from damage by drugs, as can happen with cancer therapies and from conditions such as heart attack. We are also looking at how to protect the heart from the long-term effects of surgery for congenital heart disease.
In my free time, I enjoy the symphony and collecting prints and lithographs.
Medical School: University of London.
Research Training: Doctorate of Medicine, University of London.
Fellowship: Adult cardiology, pediatric cardiology, The Royal Brompton Hospital, London, England.
Heart, Pulmonary Hypertension, Adult Congenital Heart Disease
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Lifetime Burden of Morbidity in Patients With Isolated Congenital Ventricular Septal Defect. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2023; 12:e027477.
Entrustable Professional Activities and Their Relevance to Pediatric Cardiology Training. Pediatric Cardiology. 2023; 44:757-768.
Regionalization or Access to Care? A Joint Pediatric Heart Care Program That Achieves Both: One Program-Two Sites. World Journal for Pediatric and Congenital Hearth Surgery. 2023; 14:155-160.
Survival of patients with congenital ventricular septal defect. European Heart Journal (Elsevier). 2023; 44:54-61.
Congenital Heart Surgery Program Variable Case Mix: Risk Associated With Adjusted Mortality Rate. Annals of Thoracic Surgery. 2023; 115:152-157.
Managing uncertainty in decision-making of common congenital cardiac defects. Cardiology in the Young. 2022; 32:1705-1717.
Management of Neonates Admitted With Tetralogy of Fallot: Changing Patterns Across the United States. Annals of Thoracic Surgery. 2022; 114:1419-1426.
Commentary: Invasive, but indispensable: Hemodynamic assessment to comprehend interventricular interactions. Journal of Thoracic and Cardiovascular Surgery. 2022; 163:e309-e310.
The Long-term Mortality and Burden of Morbidity Among Patients with Congenital Ventricular Septal Defects. International journal of cardiology congenital heart disease. 2022; 7:100347.
Medical education and training within congenital cardiology: current global status and future directions in a post COVID-19 world. Cardiology in the Young. 2022; 32:185-197.